StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of China Pharma stock opened at $0.25 on Monday. The business has a fifty day simple moving average of $0.29 and a 200 day simple moving average of $0.39. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17. China Pharma has a 12 month low of $0.24 and a 12 month high of $2.05.
China Pharma (NYSE:CPHI – Get Free Report) last posted its earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $1.37 million for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- What Do S&P 500 Stocks Tell Investors About the Market?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Pros And Cons Of Monthly Dividend Stocks
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How Investors Can Find the Best Cheap Dividend Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
